First Horizon Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497 | Sell |
6
-344
| -98% | -$28.5K | ﹤0.01% | 2255 |
|
|
2025
Q1 | $28.4K | Hold |
350
| – | – | ﹤0.01% | 1176 |
|
|
2024
Q4 | $31.5K | Hold |
350
| – | – | ﹤0.01% | 1155 |
|
|
2024
Q3 | $34.6K | Hold |
350
| – | – | ﹤0.01% | 1154 |
|
|
2024
Q2 | $32.4K | Hold |
350
| – | – | ﹤0.01% | 1107 |
|
|
2024
Q1 | $33.2K | Sell |
350
-471
| -57% | -$44.7K | ﹤0.01% | 1143 |
|
|
2023
Q4 | $73.3K | Buy |
821
+250
| +44% | +$22.3K | ﹤0.01% | 764 |
|
|
2023
Q3 | $41.7K | Hold |
571
| – | – | ﹤0.01% | 924 |
|
|
2023
Q2 | $47.5K | Hold |
571
| – | – | ﹤0.01% | 907 |
|
|
2023
Q1 | $43.5K | Buy |
571
+221
| +63% | +$16.8K | ﹤0.01% | 938 |
|
|
2022
Q4 | $29.1K | Hold |
350
| – | – | ﹤0.01% | 1112 |
|
|
2022
Q3 | $28K | Hold |
350
| – | – | ﹤0.01% | 1091 |
|
|
2022
Q2 | $26K | Sell |
350
-9
| -3% | -$669 | ﹤0.01% | 1196 |
|
|
2022
Q1 | $32K | Hold |
359
| – | – | ﹤0.01% | 766 |
|
|
2021
Q4 | $40K | Hold |
359
| – | – | ﹤0.01% | 1018 |
|
|
2021
Q3 | $45K | Buy |
359
+350
| +3,889% | +$43.9K | ﹤0.01% | 952 |
|
|
2021
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 1916 |
|
|
2021
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 1827 |
|
|
2020
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1423 |
|
|
2014
Q2 | – | Sell |
-1,200
| Closed | -$57K | – | 1587 |
|
|
2014
Q1 | $57K | Hold |
1,200
| – | – | 0.01% | 483 |
|
|
2013
Q4 | $52K | Hold |
1,200
| – | – | 0.01% | 478 |
|
|
2013
Q3 | $52K | Buy |
+1,200
| New | +$52K | 0.01% | 445 |
|